PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model
about
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemiaSelective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformationFOXM1 is a therapeutic target for high-risk multiple myeloma.The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
P2860
PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
PTPROt-mediated regulation of ...... phenotype in a CLL mouse model
@ast
PTPROt-mediated regulation of ...... phenotype in a CLL mouse model
@en
type
label
PTPROt-mediated regulation of ...... phenotype in a CLL mouse model
@ast
PTPROt-mediated regulation of ...... phenotype in a CLL mouse model
@en
prefLabel
PTPROt-mediated regulation of ...... phenotype in a CLL mouse model
@ast
PTPROt-mediated regulation of ...... phenotype in a CLL mouse model
@en
P2093
P2860
P356
P1433
P1476
PTPROt-mediated regulation of ...... phenotype in a CLL mouse model
@en
P2093
F W Frissora
N Muthusamy
T Motiwala
P2860
P2888
P304
P356
10.1038/LEU.2014.341
P577
2014-12-08T00:00:00Z